Patents by Inventor Alexander B. H. Bakker

Alexander B. H. Bakker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7959922
    Abstract: The present invention provides pharmaceutical antibody formulations, in particular liquid pharmaceutical formulations comprising anti-rabies virus antibodies. The formulations can be used in the post exposure prophylaxis of rabies.
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: June 14, 2011
    Assignee: Crucell Holland B.V.
    Inventors: Alexander B. H. Bakker, Willem E. Marissen
  • Publication number: 20100129374
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Application
    Filed: January 25, 2010
    Publication date: May 27, 2010
    Applicant: SCHERING CORPORATION
    Inventors: Alexander B.H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Publication number: 20100034829
    Abstract: The present invention provides pharmaceutical antibody formulations, in particular liquid pharmaceutical formulations comprising anti-rabies virus antibodies. The formulations can be used in the post exposure prophylaxis of rabies.
    Type: Application
    Filed: December 4, 2007
    Publication date: February 11, 2010
    Applicant: Cruell Holland B.V.
    Inventors: Alexander B. H. Bakker, Willem E. Marissen
  • Patent number: 7659093
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: February 9, 2010
    Assignee: Schering Corporation
    Inventors: Alexander B. H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Publication number: 20090263403
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Application
    Filed: June 26, 2009
    Publication date: October 22, 2009
    Applicant: SCHERING CORPORATION
    Inventors: Alexander B.H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Patent number: 7579446
    Abstract: The invention provides binding molecules that specifically bind to rabies virus and are capable of neutralizing the virus. The invention further provides nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from rabies virus. Preferably, they can be used in the post-exposure prophylaxis of rabies.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: August 25, 2009
    Assignee: Crucell Holland B.V.
    Inventors: Alexander B. H. Bakker, Willem E. Marissen, Robert A. Kramer, Cornelius A. de Kruif
  • Publication number: 20080292623
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Application
    Filed: December 19, 2007
    Publication date: November 27, 2008
    Applicant: Schering Corporation
    Inventors: Alexander B.H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Publication number: 20080171035
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Application
    Filed: January 25, 2008
    Publication date: July 17, 2008
    Applicant: SCHERING CORPORATION
    Inventors: Alexander B.H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Patent number: 7332574
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Grant
    Filed: February 10, 2004
    Date of Patent: February 19, 2008
    Assignee: Schering Corporation
    Inventors: Alexander B. H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Patent number: 7319140
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Grant
    Filed: February 10, 2004
    Date of Patent: January 15, 2008
    Assignee: Schering Corporation
    Inventors: Alexander B. H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Patent number: 6953843
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Grant
    Filed: July 8, 2002
    Date of Patent: October 11, 2005
    Assignee: Schering Corporation
    Inventors: Alexander B. H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Publication number: 20040177391
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Application
    Filed: February 10, 2004
    Publication date: September 9, 2004
    Inventors: Alexander B.H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Publication number: 20040132085
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Application
    Filed: February 10, 2004
    Publication date: July 8, 2004
    Applicant: Schering Corporation, a New Jersey corporation
    Inventors: Alexander B.H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • Patent number: 6416973
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: July 9, 2002
    Assignee: Schering Corporation
    Inventors: Alexander B. H. Bakker, Joseph H. Phillips, Lewis L. Lanier